Evidence map›Paper›PMID 23443804›Full record

ArticleMolecular cancer therapeutics2013

Activity of a Py-Im polyamide targeted to the estrogen response element.

Nicholas G Nickols, Jerzy O Szablowski, Amanda E Hargrove, Benjamin C Li, Jevgenij A Raskatov, Peter B Dervan

Open access · greenAbstract read
In one paragraph

Article in Molecular cancer therapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Repression of the transcriptional activity of ERRα with sequence-specific DNA-binding polyamides.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nicholas G NickolsDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Jerzy O Szablowski
Amanda E Hargrove
Benjamin C Li
Jevgenij A Raskatov
Peter B Dervan
California Institute of Technology · USUniversity of California, Los Angeles · US

Funding

SITE SPECIFIC CHEMICAL METHODS FOR CLEAVING GENOMIC DNAR01GM051747 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI DERVAN, PETER B · 1995 to 2014
$6.2M
DNA-binding polyamides as Hedgehog inhibitors in human carcinomaF32CA156833 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HARGROVE, AMANDA E · 2011 to 2012
$97k
NCI NIH HHS 1F32CA156833NCI NIH HHS F32 CA156833NIGMS NIH HHS GM-51747NIGMS NIH HHS R01 GM051747
6 · The paper itself

Abstract

Pyrrole-imidazole (Py-Im) polyamides are a class of programmable DNA minor groove binders capable of modulating the activity of DNA-binding proteins and affecting changes in gene expression. Estrogen receptor alpha (ERα) is a ligand-activated hormone receptor that binds as a homodimer to estrogen response elements (ERE) and is a driving oncogene in a majority of breast cancers. We tested a selection of structurally similar Py-Im polyamides with differing DNA sequence specificity for activity against 17β-estadiol (E2)-induced transcription and cytotoxicity in ERα positive, E2-stimulated T47DKBluc cells, which express luciferase under ERα control. The most active polyamide targeted the sequence 5'-WGGWCW-3' (W = A or T), which is the canonical ERE half site. Whole transcriptome analysis using RNA-Seq revealed that treatment of E2-stimulated breast cancer cells with this polyamide reduced the effects of E2 on the majority of those most strongly affected by E2 but had much less effect on the majority of E2-induced transcripts. In vivo, this polyamide circulated at detectable levels following subcutaneous injection and reduced levels of ER-driven luciferase expression in xenografted tumors in mice after subcutaneous compound administration without significant host toxicity.

Indexed as

AnimalsBase SequenceBinding SitesBreast NeoplasmsCell Line, TumorCluster AnalysisEstrogen Receptor alphaEstrogensFemaleGene ExpressionGene Expression ProfilingGene Expression Regulation, NeoplasticGenes, ReporterHumansMiceNylonsEstrogen Receptor alphaEstrogensNylons

Identifiers

PMID23443804
PMCPMC3651785
OpenAlexW2097877814

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.